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Abstract
Background:  We have recently reported the expression of murine Implantation Serine
Proteinase genes in pre-implantation embryos (ISP1) and uterus (ISP1 and ISP2). These proteinases
belong to the S1 proteinase family and are similar to mast cell tryptases, which function as
multimers.
Results: Here, we report the purification and initial characterization of ISP1 and 2 with respect to
their physico-chemical properties and physiological function. In addition to being co-expressed in
u t e r u s ,  w e  s h o w  t h a t  I S P 1  a n d  I S P 2  a r e  a l s o  co-expressed in the pre-implantation embryo.
Together, they form a heterodimer with an approximate molecular weight of 63 kD. This complex
is the active form of the enzyme, which we have further characterized as being trypsin-like, based
on substrate and inhibitor specificities. In addition to having a role in embryo hatching and
outgrowth, we demonstrate that ISP enzyme is localized to the site of embryo invasion during
implantation and that its activity is important for successful implantation in vivo.
Conclusion: On the basis of similarities in structural, chemical, and functional properties, we
suggest that this ISP enzyme complex represents the classical hatching enzyme, strypsin. Our
results demonstrate a critical role for ISP in embryo hatching and implantation.
Background
Embryo implantation is a necessary stage in fetal develop-
ment: in order to gain access to nutrients and gas
exchange, the embryo attaches to the uterine epithelium
and invades into the endometrium. It is a multi-step proc-
ess that consists of: the hatching of the blastocyst from the
zona pellucida, adhesion of the blastocyst to the uterine
epithelium, stromal invasion and reorganization. This
process is orchestrated through the coordinated, recipro-
cal interaction between the embryo and uterus and is
mediated via a variety of molecules including steroid hor-
mones, cytokines, adhesion molecules, proteinases and
their inhibitors [1-4].
Proteinases of different classes have been hypothesized to
give the blastocyst its invasive character and/or participate
in the remodelling of the uterine stroma. Alfonso et al [5]
have reported that cysteine proteinases play a critical role
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in implantation, and there have been several reports
implicating matrix metalloproteinases (MMPs) in this
process [6-8]. Different serine proteinases are also known
to be expressed in a finely regulated pattern during
implantation, including urokinase-type plasminogen acti-
vator (uPA) and proprotein convertase SPC5/6 [9,10].
However, the targeted disruption of several murine protei-
nase genes, presumed essential for implantation, has indi-
cated that many are dispensable, suggesting that other
distinct proteinases may be involved [1,11].
In order to discover additional serine proteinases with
potential involvement in implantation, we identified two
novel implantation serine proteinase genes (ISP1 and 2).
These were found to be co-expressed in mouse uterine
endometrium throughout the peri-implantation period
and tandemly organized within a bed of tryptase genes on
mouse chromosome 17A3.3 [12]. ISP1 gene expression
was first detected in pre-implantation embryos [13]. Anti-
sense disruption of ISP1 gene expression prevented
embryo hatching and outgrowth in vitro [13]. Both ISP1
and 2 gene expression was also detected in the uterine
endometrial gland, under the positive influence of proges-
terone [14,15]. Using immunoblotting, both ISP proteins
were detected in the uterine fluid on day 4 of pregnancy,
just prior to the commencement of implantation [16].
This appearance of protein in the glands and uterine fluid
seems to be negatively regulated by estrogen, such that
both ISP proteins appear in the uterine fluid shortly after
the estrogen spike synchronizes uterine-embryo receptiv-
ity and the commencement of implantation [16]. Interest-
ingly, antibodies directed against ISP2 protein have
recently been found to abrogate implantation, suggesting
an important role for the ISPs in implantation [17].
Mast cell tryptases are known to exist in multimeric form
[18]. Since the ISPs are co-expressed in endometrial
glands, we previously hypothesized that they exist as het-
ero-tetramers, a theory that was supported by protein
modelling studies [15]. In this study, we have purified a
heterodimeric 63 kD ISP enzyme complex from day four
pregnant mouse uterus, which is comprised of ISP1 (30
kD) and ISP2 (33 kD) monomers. The same enzyme com-
plex was detected in uterine fluid and pre-implantation
embryos. Enzyme kinetic studies have demonstrated the
affiliation of ISP enzyme complex with S1 proteinases,
having trypsin-like substrate specificity. Immunohisto-
chemistry suggests the ISP enzyme complex localizes to
the site of embryo invasion during implantation. Gabex-
ate mesylate, a potent tryptase inhibitor, was found to
inhibit ISP activity, and arrest hatching and outgrowth of
embryos in vitro, and implantation in utero. These results
demonstrate that ISP enzyme complex plays a critical role
in initiating murine implantation.
Results
Characterization and Purification of the ISP1-ISP2 enzyme 
complex
We have characterized the expression of the ISPs in uter-
ine tissue, uterine fluid and blastocysts. Uterine tissue
homogenate and intra-uterine fluid from CD1 mice at the
peri-implantation period were probed for the presence of
ISPs using mAbs (Fig. 1A and 1B). Under denaturing con-
ditions, monomers of both ISP1 (30 kD) and ISP2 (33
kD) proteins were found in highly enriched uterine tissue
homogenates and uterine fluid. In addition to the mono-
mers, an upper band (~63 kD), presumably a complex of
ISP1 and ISP2 was also obtained when either anti-ISP1 or
anti-ISP2 mAb were used to probe (Fig. 1). This 63 kD
band exhibits proteolytic activity in gel when N-Benzoyl
Arginine p-Nitroanilide (BAPNA) is used as a substrate
(Fig. 1C). The other two bands obtained (Fig. 1) were
identified as IgG light (27 kD) and heavy (54 kD) chains
by mass spectrometry analysis. The existence of IgGs in
the uterine tissue homogenates and uterine fluid can be
explained by the vascular nature of pre-implantation
uteri, such that blood serum products are found in high
abundance. A similar enzyme complex was also detected
in mouse blastocysts in western blots using denaturing
conditions (Fig. 2A and 2B). As we had previously not
detected ISP2 expression in the embryo, we used RT-PCR
to confirm that ISP2 was indeed expressed in the preim-
plantation embryo (Fig. 2C). Following upon our previ-
ous observation of ISP1 and ISP2 co-expression in uterine
glands [15] and now embryos (this study), as well as this
higher molecular weight complex in the gels, we used co-
immunopreciptation to investigate the possibility that ISP
monomers formed hetero-dimeric complexes. Co-IPs
were performed by cross-linking anti-ISP mAbs to acti-
vated agarose beads followed by affinity purification of
the respective proteins from the uterine tissue homoge-
nates. The bound antibodies were able to precipitate their
cognate protein targets (Fig. 3C), as well as their corre-
sponding opposite ISP (Fig. 3D). These results lend cre-
dence to the idea that ISP1 and ISP2 hetero-dimerize to
form a higher molecular weight enzyme.
The native ISP enzyme complex was purified from mouse
uterine tissue homogenates (uteri collected at 4.5 dpc –
6.5 dpc stage of pregnancy) by ammonium sulphate pre-
cipitation of homogenized tissue, followed by multi-step
column chromatography. Several different methods of
separation were tested to serve as the first chromatography
step. These included an inhibitor affinity method using
Benzamidine-sepharose (Fig. 3A), ion exchange chroma-
tography (DEAE sepharose and CM-sepharose), and
hydrophobic interaction chromatography. DEAE sepha-
rose gave the best results in terms of yield and was then
followed by a two-step gel filtration using Superdex-200
and Superdex-75 (Fig. 3B). The purity of the enzyme com-BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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plex was confirmed by native gel electrophoresis after
purification (Additional file 1. Fig. 1a). The purified frac-
tion is enzymatically active and exhibits enzyme activity
in gel. The native size of the complex was found to be
approximately 60 kD when analysed by gel filtration
using molecular weight standards (Additional file 1. Fig.
1b). Additionally, the identity of the subunits was con-
firmed by mass spectrometry analysis.
Enzyme Kinetics
To determine the substrate specificity of the ISP complex
and to classify it into a subclass of the S1 family of serine
proteinases, enzyme assays were carried out using differ-
ent p-nitroanilide linked peptide (1–3 mer) substrates.
These included chymotrypsin-like (Tyr/Phe at cleavage
(P1) site), trypsin-like (Arg/Lys at P1 position), elastase-
like (Ala at P1 position), and subtilisin-like (Leu at P1
position) substrates. The results obtained are shown in
figure 4A. In order to compare affinity of specific sub-
strates and derive Michaelis Menton constant (Km) val-
ues, the kinetic curves were plotted (substrate conc. [S] vs.
rate of reaction [v]). A trypsin-specific substrate, N-ben-
zoyl Phe-Val-Arg p-nitroanilide, showed the best affinity
towards the ISP enzyme complex.
Many general serine proteinase inhibitors were tested in
order to identify suitable ISP inhibitors when BAPNA was
used as a substrate. These included Benzamidine hydro-
chloride, 4-(Amidino-Phenyl)-Methane-Sulfonyl Fluo-
ride (APMSF), L-1 Chloro-3- [4-tosyl-amido]-7-amino-2-
heptanone. HCl (TLCK), Trypsin Soybean Inhibitor (TSI),
Bis (5-amidino-2-benzimadozolyl) methane (BABIM),
Gabexate mesylate, Nafamostat, and the kunitz family ser-
Characterization of blastocyst ISP expression Figure 2
Characterization of blastocyst ISP expression. A and 
B- Western blot analysis showing the expression of the ISP1- 
ISP2 enzyme complex from 3.5 dpc blastocysts when probed 
with anti-ISP1 (A) and anti-ISP2 (B) mAbs. C- RT-PCR from 
pre-implantation embryos. Lanes 1–4 and 6–10 represent 
samples amplified using ISP1 and ISP2 primers, respectively: 
lanes 4 and 6: non-pregnant uterus cDNA (negative control); 
lanes 3 and 7: 2.5 dpc embryo cDNA; lanes 2 and 8: 3.5 dpc 
embryo cDNA; lanes 1 and 9 represent 4.5 dpc embryo 
cDNA. Lane 5 is the 1 kb plus DNA ladder.
Characterization of uterine ISP expression Figure 1
Characterization of uterine ISP expression. A- West-
ern blot results showing the expression of the ISP1-ISP2 
complex from mice uterine homogenates (lane 1) and intra-
uterine fluid (lane 2) collected at the peri-implantation period 
(4.5 dpc – 5.5 dpc) probed with anti-ISP1 monoclonal anti-
body, B- Western blot results showing the expression of the 
ISP1-ISP2 complex from mice uterine homogenates (lane 1) 
and intra-uterine fluid (lane 2) collected at the peri-implanta-
tion period (4.5 d pc – 6.5 d pc) probed with anti-ISP2 mono-
clonal antibody, C- A zymogram showing in-gel enzyme 
activity of ISP1-ISP2 enzyme complex, carried out by using 5 
mM BAPNA as substrate (lane 1- uterine tissue homogenate, 
lane 2- uterine fluid).BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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pins Uterine Plasmin-Trypsin Inhibitor (UPTI) and Secre-
tary Leukocyte proteinase inhibitor (SLPI).
Only inhibitors specific for trypsin-like serine proteinases
were able to inhibit the ISPs (Fig. 4B and Additional file 2.
Table 1). IC50 (concentration of an inhibitor capable of
inhibiting the enzyme activity by 50%) values were
obtained by plotting inhibition data, which were extrapo-
lated into Cheng and Prusoff's [19] equation to derive the
dissociation constant (Ki).
Hatching and Implantation studies
Previously we have determined that both embryo hatch-
ing and outgrowth in vitro were inhibited by antisense oli-
gonucleotides, which abrogated ISP1 gene expression
[13]. In further immunohistochemistry experiments, we
have determined that both ISP1 and ISP2 localize to the
embryo-uterine boundary during implantation (Fig. 5A, B
and 5C).
In order to define a physiological role for the ISPs, the
effect of inhibiting ISP activity upon embryo hatching,
outgrowth (Fig. 6 and 7) and implantation (Table 1) was
investigated. Blastocysts were first cultured in the presence
or absence of anti-ISP mAbs or selected inhibitors. Differ-
ent concentrations of anti-ISP antibodies and inhibitors
(Benzamidine, Gabexate and BABIM) were tried in order
to eliminate their toxic concentrations from influencing
results (Additional file 2. Tables 2 and 3). Figure 7A dem-
onstrates the effect of two different concentrations of
Gabexate on the hatching of blastocysts in comparison to
controls. Here, an incremental decrease in the rate of
Purification of the uterine ISP enzyme complex Figure 3
Purification of the uterine ISP enzyme complex. A- FPLC chromatogram displaying the affinity purification of ISP1-ISP2 complex from mouse uter-
ine homogenates using a Benzamidine Sepharose column. The inset shows the Western Blot results of this partially purified fraction (lane 1: ISP1-ISP2 
complex probed with anti-ISP1 antibody, lane 2: ISP1-ISP2 complex probed with anti-ISP2 antibody). B- FPLC chromatogram displaying the separation of 
ISP1-ISP2 complex using a Superdex™-200 column. The inset shows the Western blot results of the fraction purified from mouse uterine homogenates by 
ion exchange chromatography (DEAE-Sepharose) followed by gel filtration using Superdex™-200 and Superdex™-75 columns (lane 1: ISP1-ISP2 complex 
probed with anti-ISP1 antibody, lane 2: ISP1-ISP2 complex probed with anti-ISP2 antibody). C- Affinity purification of ISPs by immunoprecipitation (1- 
eluted ISP1 fraction pulled down by anti-ISP1 antibody covalently bound to acrylamide activated agarose beads in a chromatography column, 2 – eluted 
ISP2 fraction pulled down by anti-ISP2 antibody covalently bound to acrylamide activated agarose beads in a chromatography column). D- Co-immunopre-
cipitation of ISPs (1- Fraction from section C1 probed with anti-ISP2 antibody, 2- Fraction from section C2 probed with anti-ISP1 antibody.BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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Table 1: Effect of Gabexate mesylate on pregnancy.
Group # mice # pregnant # embryos Rate (%)
Control 1 6 6 72 100
Gabexate 1 11 1 2 2.8
Control 2 4 4 22 100
Gabexate 2 6 1 3 13.6
Uterine horns of 2.5 dpc pregnant dams were injected with 10 ul each of saline (control) or the Gabexate mesylate (10 mM). Animals were 
sacrificed and examined for pregnancies at 7.5 dpc. % Rate of pregnancy was calculated by assuming the rate of pregnancy in Controls as 100%.
ISP enzyme kinetics Figure 4
ISP enzyme kinetics. A- Affinity of different synthetic chromogenic substrates (N-Benzoyl-DL-Arginine-β-Naphthylamide 
[BANA], N-Benzoyl-DL-Arginine-p-NA [BAPNA], N-Benzoyl-L-Arginine Ethyl Ester [BAEE], N-Benzoyl-Phe-Val-Arg-pNA 
[BPVANA], N-Benzoyl-L-Tyrosine-pNA [BTNA], N-Succinyl-L-Phe-pNA  [SPNA], N-Succinyl-Ala-Ala-Ala-pNA [SAANA], N-
CBZ-Gly-Gly-Leu-pNA [CGGLNA], Ile-Pro-Lys-pNA [IPLNA], N-Tosyl-Gly-Pro-Lys-pNA [TGPLNA], Val-Pro-Lys-pNA 
[VPLNA]) for the ISP1-ISP2 enzyme complex. The trypsin substrate BPVANA showed the greatest affinity to the enzyme com-
plex. B- Enzyme inhibition data showing the affinity of different serine proteinase inhibitors to the ISP1-ISP2 enzyme complex. 
TSI, Gabexate and BABIM have a relatively high affinity for ISP enzyme, compared to Benzamidine.BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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hatching is noticeable with increasing Gabexate concen-
tration. Although kinetic studies showed that BABIM was
a more effective inhibitor (Ki = 0.204 mM) than Gabexate
(Ki = 0.49 mM), limited quantities of this inhibitor pre-
vented a significant in vitro hatching/outgrowth analysis.
Similarly, the effect of varying concentrations of anti-ISP1
and anti-ISP2 mAbs was studied both individually and
together (Fig. 7C, E and 7G). The results obtained clearly
show that anti-ISP mAbs can efficiently arrest blastocyst
hatching compared to controls (Fig. 6A and 6B).
Implantation was simulated in vitro by growth of the
hatched blastocysts in culture plates coated with the extra-
cellular matrix derived from mouse embryonic fibrob-
lasts, which can be invaded by outgrowing embryos (Fig.
6C and 6D). Different concentrations of anti-ISP antibod-
ies and Gabexate were tried as shown in figures 7B, D, F
and 7H. The effect of Gabexate on blastocyst outgrowth is
also incremental with increasing concentration of Gabex-
ate (Fig. 7B). Individually, anti-ISP1 and anti-ISP2 mAbs
did not seem to have a significant effect on embryo out-
growth (Fig. 7D and 7F). However, when administered
together, anti-ISP antibodies led to an arrest/delay in
embryo outgrowth (Fig. 7H). Gabexate also had a signifi-
cant effect on embryo implantation in vivo. When admin-
istered topically to the uterus by injecting into the lumen
at 2.5 dpc, the rate of pregnancy drops to very low in com-
parison to controls (Table 1). A similar result was not
observed for individual or combined mAbs, possibly
owing to the abundance of ISP enzyme that occurs within
the uterine fluid.
Discussion and Conclusion
We have previously demonstrated that the ISPs are tan-
demly linked genes, which are co-regulated in the uterine
endometrial gland during the peri-implantation period
[12,15]. ISP gene expression leads to the secretion of both
ISP1 and ISP2 into uterine fluid at the time of hatching
and initiation of implantation [16]. In this report, we
show that the ISPs are also co-expressed in pre-implanta-
tion embryos, consistent with the idea that they may also
be co-regulated in the pre-implantation embryo. These
observations are consistent with our observation that ISP1
and ISP2 form a hetero-dimeric complex. Upon purifica-
tion of ISP enzyme complex from pregnant uterus and
confirmation by immunoblotting and mass spectrometry,
we determined its molecular weight to be ~63 kD, with
the ISP1 and ISP2 monomers being ~30 and 33 kD,
respectively. These molecular weights are consistent with
our previous study, where we characterized the appear-
ance of ISP monomers in uterine fluid during the peri-
implantation period [16]. However, our results contradict
a previous report of ISP2 as having a molecular weight of
48 kD [17].
Inhibition of embryo hatching and outgrowth Figure 6
Inhibition of embryo hatching and outgrowth. A, C- 
Control mAb-treated blastocysts showing the normal hatch-
ing and outgrowth, respectively. B, D- ISP1/2 mAB-treated 
blastocysts showing arrested hatching and outgrowth respec-
tively.
ISP protein localization at the site of implantation Figure 5
ISP protein localization at the site of implantation. A, 
B and C- Immunohistochemistry analysis showing ISP1 and 
ISP2 protein at the 4.5 dpc implantation site. A- Section 
stained with secondary antibody only; B- Section stained with 
anti-ISP1 mAb and secondary antibody; C- Section stained 
with anti-ISP2 mAb and secondary antibody.BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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Effect of inhibitors and antibodies on hatching and invasion Figure 7
Effect of inhibitors and antibodies on hatching and invasion. In vitro hatching and outgrowth of blastocysts when grown 
in culture medium supplemented with different concentrations of Gabexate mesylate, anti-ISP1/-ISP2 mAbs (blue: embryos per 
set; purple: hatched after 24 h/outgrown after 48 h; white: hatched after 48 h/outgrown after 72 h). A – Effect of Gabexate on 
hatching (P value – 0.03). B – Effect of Gabexate on outgrowth (P value – 0.006). C – Effect of anti-ISP1 mAb on hatching (P 
value – 0.03). D – Effect of anti-ISP1 mAb on outgrowth (P value – not significant). E – Effect of anti ISP2 mAb on hatching of 
blastocysts (P value at 24 hrs. – 0.02; at 48 hrs. – not significant). F – Effect of anti-ISP2 mAb on the outgrowth of hatched blas-
tocysts (P value – not significant). G – Effect of anti-ISP1/ISP2 mAb on the hatching of blastocysts (P value – 0.003). H – Effect 
of anti-ISP1/ISP2 mAb on the outgrowth of hatched blastocysts (P value – 0.006).BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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We have suggested that the ISPs are members of the mast
cell tryptase family [13,14] and have demonstrated that
the ISP genes reside in a tryptase cluster on mouse chro-
mosome 17A3.3 [12]. In this study we have used synthetic
substrates to classify ISP enzyme complex based on its
enzymatic activity. Consistent with our previous sugges-
tions, we have sub-classified ISP enzyme complex as being
trypsin-like since; it does not show any reactivity with syn-
thetic serine proteinase substrates specific for chymot-
rypsin, subtilisin or elastase. Hence, ISP enzyme can only
cleave peptides that contain arginine or lysine at the P1
position, with arginine being the preferred choice.
Amongst the substrates tested, BPVANA has the highest
affinity towards the enzyme (Km = 0.06 mM) demonstrat-
ing preference of a tripeptide having valine at P2 position
and phenylalanine at P3 position over the other peptide
substrates. Currently, work is in progress to further define
the substrate preferences of ISP using phage display pep-
tide mimetics.
The ISP genes are most closely related to their neighbours
MMCP6 and 7, which have previously been shown to exist
as homo-tetrameric enzymes [18]. Based on previous in
silico molecular modelling, we have postulated that ISP1
and ISP2 exist as hetero-tetramers [15]. Following on our
finding that the ISPs do not seem to tetramerize in vitro,
we have examined the properties of tryptases, which pro-
mote tetramer formation. Although the ISPs possess the
hydrophobic domain containing eight Trp residues
important for tetramer formation [20], they lack two of
the three surface-exposed His residues that are necessary
for MMCP6 tetramerization [21]. Interestingly, in this
regard, at least one other tryptase in this cluster, tryptase γ,
has been speculated to form only dimers [22]. Although
we demonstrate at this time that ISP1 and ISP2 form het-
erodimers, we do not know if this is exclusive, or whether
the ISPs can also homodimerize. Our observation that
ISP1 and ISP2 mAbs can block embryo hatching and/or
outgrowth, only when applied in combination, suggests
the possibility that homo-dimers not only exist, but can
also function in embryo hatching and invasion.
Previously, we have reported that the antisense abroga-
tion of ISP1 expression in blastocysts resulted in the inhi-
bition of hatching from the zona pellucida and  in vitro
outgrowth into extracellular matrix [14]. We have sug-
gested that embryonic ISP enzyme represents the murine
hatching enzyme strypsin, which is secreted from blasto-
cysts and predicted to be ~74 kD based on autoradiogra-
phy [24]. In this study, several general trypsin inhibitors
including Benzamidine, APMSF, TLCK, Gabexate
mesylate, BABIM and TSI showed an inhibitory influence
on ISP activity. Amongst them TSI exhibited the highest
affinity for the ISP enzyme complex (Ki = 2.18 µM). Our
results agree with the previous characterization of stypsin,
which demonstrated that trypsin inhibitors had a signifi-
cant inhibitory effect on blastocyst hatching. Like ISP, TSI
was the strongest inhibitor of strypsin activity. Like
strypsin, ISP demonstrates the highest affinity towards
inhibitors of 'trypsin like' activity; and doesn't catalyse the
cleavage of chymotrypsin or elastase substrates.
In this study, we have confirmed a role for ISP in embryo
hatching and outgrowth. When exposed to gabexate
mesylate, a synthetic inhibitor of tryptases [25] and ISP
(this study), both in vitro embryo hatching and outgrowth
were almost completely inhibited. Similarly, administra-
tion of anti-ISP1 and anti-ISP2 monoclonal antibodies
also led to a delay in hatching and outgrowth in vitro.
Together these results suggest that ISP plays a vital role
during embryo implantation, likely at the level of zona pel-
lucida  lysis and the initiation of invasion into uterine
endometrium.
Interestingly, immunohistochemistry of implanting
embryos shows that ISP enzyme complex surrounds the
invading embryo, highlighting their importance in
implantation. At this time, it is not clear whether this peri-
implantation ISP staining is strictly from the embryo or
whether ISP complex that resides in uterine fluid is also
recruited to sites of embryo invasion. However, inhibition
of ISP activity in vivo via the topical application of gabex-
ate had a significant negative effect on implantation.
Although we cannot rule out the involvement of other
proteinases in the process of hatching and implantation at
this time, ISP appears to be an essential link in the cascade
of events. Presently, we are disrupting the ISP genes to
genetically confirm their role in hatching and implanta-
tion. We are also characterizing the substrates and protein
targets of ISP in order to better understand the process of
implantation. This could in turn lead to the design of
more specific synthetic inhibitors of ISP and the develop-
ment of new and more potent contraceptives.
Methods
Substrates and Inhibitors
p-Nitroanilide substrates, Benzamidine Hydrochloride,
TLCK (N -p-tosyl-L-lysine chloromethyl ketone), APMSF
(4-Amidino-Phenyl)-Methane-Sulfonyl Fluoride),
Trypsin Soybean Inhibitor (TSI) and Gabexate mesylate
were obtained from Sigma Aldrich and Co. Dr. George H.
Caughey, University of California, San Francisco kindly
supplied BABIM.
Kunitz type UPTI like recombinant inhibitors were kindly
provided by Dr. Jonathan Green (University of Missouri).
Handling of mice
CD1 mice were obtained at the age of 6–8 weeks from
Charles River Canada (St. Constant, Quebec) and main-BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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tained in a standard laboratory animal facility with con-
trolled temperature (20°C), humidity and light cycle
(lights on between 0700 and 1900 hr). The maintenance
and treatment of animals was in full compliance with the
Standard laboratory animal care protocols approved by
the University of Calgary Animal Care Committee. To
obtain natural pregnancies, female mice were paired with
adult males and checked daily for the presence of vaginal
copulatory plugs, as an indication of mating. The day of
plug detection is designated as day 0.5 post coetum. For
collection of uteri and embryos, pregnant dams were sac-
rificed on a specific day by cervical dislocation.
Preparations of Monoclonal Antibodies
Anti-mouse ISP monoclonal antibodies (mAbs) were pre-
pared by Immuno-Precise Antibodies Ltd., Victoria, Can-
ada. Antibodies were raised against unique fragments of
(His)6 tagged ISP1 and ISP2 expressed in E. coli and puri-
fied using NiNTA chromatographic columns, as outlined
previously [16]. The effective protein concentration of
monoclonal antibodies used in subsequent experiments
was 10 mg/ml (anti-ISP1) and 5 mg/ml (anti-ISP2).
Purification of ISP1-ISP2 complex
Uteri were placed in 25 mM Tris.Cl buffer (pH-8.0) and
homogenized using a mechanical homogenizer (Kine-
matica). The homogenate was centrifuged at 10000 rpm
(Beckman JA17 rotor) for 30 min. The supernatant
obtained was subjected to fractionation by varying con-
centrations of ammonium sulphate. The precipitated frac-
tions were re-suspended and subjected to column
chromatography using the Duo Flow FPLC system (Bio-
Rad). The purification involved sequential ion exchange
(DEAE Sepharose), desalting (Sephadex G-25) and gel fil-
tration (Superdex-200 and Superdex-75) chromatogra-
phy. Affinity chromatography was also carried out using
HiTrap™ Benzamidine column (M/S Amersham).
Immunoprecipitation
Instead of traditional immunoprecipitation (IP) by using
Protein A/Protein G beads, antibody affinity columns
were made with the Amino Link Plus kit from Pierce. ISP1
and ISP2 monoclonal antibodies were covalently bound
to activated agarose beads by Schiff base chemistry and
the beads were packed into columns. These were then
used to pull the ISPs from uterine tissue homogenates,
which were then eluted using low pH conditions (25 mM
Tris.Cl pH 3.0). The various fractions obtained during
purification were analysed for enzyme activity as per the
enzyme assay protocol described below. Traditional
immunoprecipitation was also performed using Protein G
beads.
Immunoblotting
During protein purification, fractions were analysed by
PAGE (10%, 12% and 4% – 16% gradient gels) and elec-
trophoresed under denaturing or non-denaturing condi-
tions. Equal amounts of protein were loaded onto
different lanes in the same gel. The proteins were then
transferred to nitrocellulose membrane and probed with
anti-ISP monoclonal antibodies. A horseradish peroxi-
dase (HRP)-labelled anti-mouse IgG antibody (Amer-
sham) was used at a 1:10,000 dilution for detection on
BioMax film™ (Kodak).
Zymography
In-gel enzyme assays were run electrophoretically as
described in the above section. Non-reduced protein sam-
ples were loaded onto a 10% SDS polyacrylamide gel.
Electrophoresis was performed at 100 V for 1 hr. Subse-
quently, the gel was washed twice with 4% Triton- X-100
made up in distilled water for 30 min. The gel was then
rinsed thoroughly with distilled water and incubated in
25 mM Tris.Cl (pH 8.0) buffer having 5 mM N-Benzoyl
Arginine p-Nitroanilide (BAPNA) and 5 mM EDTA, over-
night at 37°C. The gel was again rinsed thoroughly with
distilled water on the following day in order to remove
any precipitation and imaged in the visible range of wave-
length to detect any bands on an otherwise transparent
gel.
Enzyme Assay and Kinetics
Chromogenic assays were carried out using the p-
Nitroanilide conjugated peptidic substrates. The reaction
conditions used were: 4 mM BAPNA (substrate), in 25
mM Tris.Cl (pH 8.0) and 10 mM EDTA reaction buffer, in
a total reaction volume of 0.5 mL. The reactions were car-
ried out at room temperature in a glass cuvette (1 cm path
length), and scanned at wavelength maxima of 405 nm
using a spectrophotometer. 1 Unit of enzyme is defined as
enzyme activity sufficient for the breakdown of 1 µM of
substrate/ml/min. The affinity of ISP complex with vari-
ous substrates was characterized by measuring enzyme
activity at differing substrate concentrations and plotting
enzyme activity [V] vs. substrate concentration [S]. The
Km was calculated using the Michaelis Menton equation
(Km = [S] at 1/2 Vmax).
The inhibition of proteolytic activity of ISP enzyme com-
plex exhibited by known serine proteinase inhibitors was
determined by determining IC50 (inhibitor concentration
capable of 50% inhibition of enzyme activity). IC50 values
were derived by plotting enzyme activity (V) vs. inhibitor
concentration [I]. Dissociation constants (Ki) values for
different inhibitors were determined by using the Cheng
and Prusoff [19] equation (Ki = IC50/1 + [S]/Km).BMC Developmental Biology 2006, 6:61 http://www.biomedcentral.com/1471-213X/6/61
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Embryo culture, in vitro Hatching and Outgrowth
Blastocysts were collected by flushing the uteri of day 3.5
post coetum dams with M2 (Sigma Aldrich and Co.)
medium [26]. For in vitro hatching experiments, blasto-
cysts were cultured in micro drops of Knockout DMEM
medium (Invitrogen) with serum replacement in a drop
under mineral oil at 37°C and 5% CO2 [27]. For in vitro
embryo outgrowth onto extracellular matrix, hatched
blastocysts were cultured for an additional 48 h at 37°C
and 5% CO2 in DMEM plus 5% (v/v) fetal bovine serum
on 35 – 60 mm2 Nunc tissue culture dishes coated with
extracellular matrix derived from 10% Triton X-100 (v/v)
treated mouse embryo fibroblasts [13]. Inhibitors or anti-
ISP mAbs were mixed into media at stated concentrations.
For antibody inhibition experiments, anti-ISP hybridoma
supernatants (or negative control supernatants) were
mixed with embryo culture media at an appropriate con-
centration. For inhibitor experiments, negative controls
contained the medium used to dispense Gabexate
mesylate.
In vivo Studies
Uterine horns were exposed surgically whereupon inhibi-
tor or anti-ISP antibodies were injected into the uterine
lumen using the minimum possible volume (10 µl fluid
was injected per horn). Since Gabexate was dissolved in
normal saline, the control mice were injected with normal
saline solution.
Preparation of Total RNA and RT-PCR
Total embryonic RNA (1 µg) was prepared from embryos
flushed from the uteri of pregnant dams at different stages
of pregnancy. RNA was isolated with Trizol (Invitrogen).
The total RNA was reverse-transcribed using Superscript II
(Life Technologies). The resulting cDNA was used as a
template for PCR using ISP1 (5'-GCGGATCCGT-
GGGGGAAGTA-3' and 5'-GCGAATTCAGCTTTGT-
GCTCG-3') and ISP2 (5'-GCGAATTCGTGGTACATCTCC-
3' and 5'-GCGGATCCTATGGGGGCAAG-3') primers. The
RT-PCR product was sequenced in order to confirm the
identity.
Immunohistochemistry
Serial 6-µm sections were cut from paraffin embedded
6.5-day mouse uteri. Sections were mounted onto Super-
frost Plus glass slides (VWR) and dried overnight at room
temperature. Paraffin was removed from sections using
xylene and re-hydrated in ethanol. Antigen retrieval was
done in 0.05% saponin (made up in sterile water) for 30
minutes at room temperature. Endogenous peroxidase
was blocked by incubation with 3% H2O2, in absolute
methanol, for 30 minutes. Non-specific binding of anti-
bodies was blocked with pre-blocking solution (Histo-
stain-plus kit, Zymed). 100 µl anti-ISP1 (10 mg/ml) or
ISP2 mAb (5 mg/ml) hybridoma supernatants (undi-
luted) were applied overnight at 4°C. Biotinylated sec-
ondary anti-mouse antibody, streptavidin conjugated
peroxidase and AEC single-solution chromogen (Histo-
stain-plus kit, Zymed) were each applied for 10 minutes at
room temperature. Three PBS (pH 7.4) washes were car-
ried out between each step, except after pre-blocking.
Slides were counterstained with hematoxylin for 2 min-
utes and mounted in Clearmont mounting solution
(Zymed). Negative controls were performed without ISP
mAbs.
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